Clinical trials
Ataxia - Other clinical trials
Below are recruiting ataxia - other clinical trials, each written for real people, not researchers. We’re tracking 69 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06600269Recruiting
Cycling training for ataxia recovery in SCA
This study tests whether cycling-based coordination training can help people with spinocerebellar ataxia (SCA) improve balance and movement by priming the brain for recovery.
TaoyuanAges 18 years+ - NCT06623890Recruiting
Long-term safety of omaveloxolone for Friedreich's ataxia
This study looks at the long-term safety of omaveloxolone (BIIB141) for people with Friedreich's ataxia. You can join if you are just starting this medicine or have been taking it for less than a year.
Los Angeles, CaliforniaAges 16 years+ - NCT06628687Recruiting
Study checking omaveloxolone health effects during pregnancy and breastfeeding
This study follows people with Friedreich's ataxia who took omaveloxolone during pregnancy or while breastfeeding, to check how the drug affected their health and their baby's health. It helps doctors understand the safety of this treatment for mothers and babies.
Morrisville, North CarolinaAges 16 years+ - NCT06633003Recruiting
Testing an oral extract for spinocerebellar ataxia
This trial tests whether an oral extract from a mushroom called Antrodia cinnamomea can help improve symptoms in people with spinocerebellar ataxia (a condition that affects coordination and balance). Participants must be able to communicate in Chinese.
TaipeiAges 30–70 - NCT06692296Recruiting
Balance training with a stabilometric platform for Friedreich's ataxia
This trial tests if a special platform that measures balance can help people with Friedreich's ataxia stand more steadily. If you have Friedreich's ataxia, can walk at least 10 metres and stand without support, you may be eligible.
Pieve di Soligo, VenetoAges 14 years+ - NCT06874010RecruitingPhase 1/Phase 2
Study of DT-216P2 in adults with Friedreich's ataxia
This trial tests an investigational drug called DT-216P2 in people with Friedreich's ataxia. It aims to find the right dose and see how safe and tolerable it is.
Sydney, New South WalesAges 18–65 - NCT06953583RecruitingPhase 3
Testing omaveloxolone for children and teens with Friedreich's Ataxia
This study tests a drug called omaveloxolone (BIIB141) for children and teens with Friedreich’s Ataxia. It looks at how well the drug works and how safe it is over a longer time.
Los Angeles, CaliforniaAges 2–15 - NCT07013292Recruiting
Omaveloxolone for swallowing issues in Friedreich's ataxia
This study looks at whether omaveloxolone (a medication) can help improve swallowing problems in people with Friedreich's ataxia. If you have been taking omaveloxolone for at least 6 months, your data may help researchers understand if it helps with swallowing.
Nice, Alpes MaritimesAges 16 years+ - NCT07019558Recruiting
Eye disorders in dominant spinal-cerebellar ataxias
This trial looks for eye problems in people with certain genetic forms of spinocerebellar ataxia (SCA1, SCA2, SCA3, or SCA27B). You have to be between 18 and 80 years old and have a specific genetic mutation. You can join if you already have symptoms or if you are at risk but do not have symptoms yet.
Montpellier, HéraultAges 18–80 - NCT07092358Recruiting
Hereditary ataxia study in the Yangtze Delta region
This study looks at genetic ataxia (a condition that affects coordination) and uses advanced testing to learn more about it. It aims to help understand the disease better and find new ways to treat it.
Hangzhou, ZhejiangAges Any age - NCT07095062Recruiting
EEG brain mapping study for Friedreich's ataxia
This study uses an EEG (a painless test that records your brain's electrical activity) to map the brain connections in people with Friedreich's ataxia. It aims to better understand how the condition affects the brain.
Conegliano, TrevisoAges 8–60 - NCT07099651Recruiting
Social understanding in spinocerebellar ataxia
This study looks at how people with certain genetic types of spinocerebellar ataxia (a condition that affects movement and coordination) understand social situations. It aims to see if there are differences in social thinking compared to people without the condition.
AngersAges 18–100 - NCT07136844Recruiting
Walking and arm movement study for nerve and muscle conditions
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
LiègeAges 18 years+ - NCT07180355RecruitingPhase 1
Gene therapy trial for Friedreich's ataxia
This trial tests a gene therapy called SGT-212 for people with Friedreich's ataxia. It aims to help treat the condition by delivering a working copy of the gene.
Los Angeles, CaliforniaAges 18–40 - NCT07185347RecruitingPhase 3
Fampridine for SCA27B ataxia study
This trial tests if fampridine, a medication, can improve walking and coordination in people with SCA27B, a specific inherited ataxia. It compares fampridine to a placebo over a period of time.
AngersAges 18 years+ - NCT07215416RecruitingPhase 1/Phase 2
Gene therapy for ataxia-telangiectasia with specific ATM mutation
This trial tests a new genetic medicine designed for people with A-T who have a specific ATM gene change. It aims to see if the treatment is safe and if it can improve symptoms.
Boston, MassachusettsAges birth–17 years - NCT03879018Recruiting
Retraining reaching movements for cerebellar ataxia
This trial tests whether practice-based training can improve reaching and hand control in people whose coordination problems come from cerebellar damage. It may help by teaching your brain new ways to plan and carry out reaching tasks.
Baltimore, MarylandAges 22–80 - NCT02440763Recruiting
Study of inherited progressive balance and coordination changes
This is a natural history study that follows people with inherited forms of “ataxia” (problems with balance and coordination) over time. It may help researchers better understand how these conditions progress in daily life and can inform future treatments.
InnsbruckAges 18 years+ - NCT02497534Recruiting
Biomarker testing study for Friedreich’s ataxia
This study looks at “biomarkers” (measurable signs in the body, like test results from blood or other checks) in people with Friedreich’s ataxia. It may help researchers understand the disease better and track changes over time.
Gainesville, FloridaAges 6–70 - NCT03336008Recruiting
Registry for certain inherited spinocerebellar ataxias
This study is a registry that collects information from adults with certain types of inherited ataxia caused by specific genetic diagnoses. It may help doctors better understand these conditions and support future research.
Hong Kong, ShatinAges 18–90 - NCT07427563Recruiting
Cerebellar deep brain stimulation for ataxia
This trial tests whether stimulating a part of the brain called the cerebellum with a device can help improve balance and coordination in people with primary ataxia (a movement disorder you were born with or inherited). It aims to see if this treatment is safe and effective over one year.
Toronto, OntarioAges 20–70 - NCT07508631Recruiting
Friedreich Ataxia Nerve Ultrasound Study
This trial uses an ultrasound to look at nerves in people with Friedreich's Ataxia. It may help doctors better understand how the condition affects the nervous system.
Nice, Alpes MaritimesAges 18–70 - NCT06267222Enrolling by invitation
Spinal electrical stimulation for spinocerebellar ataxia
This study tests a noninvasive electrical stimulation therapy applied to the spine to see if it can improve movement and coordination in people with spinocerebellar ataxia. It may help with walking and balance.
Rio de Janeiro, Rio de JaneiroAges 18–70 - NCT03286686Recruiting
Study of thinking and hand skills after brain injury
This study looks at how people with an injury to the back part of the brain (posterior parietal cortex) process what they see and guide their movements. It may help researchers better understand the symptoms and improve future therapies.
BronAges 18–75
Hear when a new Ataxia - Other trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ataxia - other?
- Yes. Clin2 currently lists 69 recruiting ataxia - other studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ataxia - other trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ataxia - other trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.